Literature DB >> 21414028

Contemporary clinical outcomes of primary percutaneous coronary intervention in elderly versus younger patients presenting with acute ST-segment elevation myocardial infarction.

Abdul Moiz Hafiz1, Muhammad Fuad Jan, Naoyo Mori, Anjan Gupta, Tanvir Bajwa, Suhail Allaqaband.   

Abstract

BACKGROUND: Primary percutaneous coronary intervention (PPCI) is the choice reperfusion strategy for acute ST-segment elevation myocardial infarction (STEMI). However, data on PPCI in elderly patients are sparse. This study determined clinical outcome post-PPCI in elderly versus younger patients with STEMI. METHODS AND
RESULTS: A cohort of 790 consecutive STEMI patients was studied for survival and major adverse cardiovascular events (MACE) after PPCI using a precise cardiac catheterization protocol. Patients were divided into two groups: those ≥75 years (elderly) and those <75 years. Median door-to-balloon time (DBT) was 82 minutes in the elderly versus 66 minutes in the younger group (P = 0.002). In-hospital all-cause mortality was higher in the elderly group (15.5% vs. 2.7%, P < 0.001). In elderly patients, MACE were found to be higher (32.3% vs. 16.1%, P < 0.001). Using a multivariate logistic regression analysis, age (odds ratio [OR]= 1.04, 95% confidence interval [CI]= 1.02-1.05, P < 0.001), diabetes (OR = 2.17, 95% CI = 1.33-3.53, P = 0.002), renal failure (OR = 3.75, 95% CI = 1.30-10.79, P = 0.014) and coronary artery disease (OR = 1.61, 95% CI = 1.00-2.59, P = 0.050) were associated with higher in-hospital MACE, while age (OR = 1.05, 95% CI = 1.02-1.08, P = 0.001), diabetes (OR = 2.18, 95% CI = 1.06-4.47, P = 0.034) and renal failure (OR = 6.65, 95% CI = 2.01-22.09, P = 0.002) were associated with higher in-hospital mortality. Kaplan-Meier 1-year survival rate was lower in the elderly.
CONCLUSIONS: In a contemporary population of STEMI patients treated with PPCI, overall in-hospital MACE and mortality remain higher in elderly compared to younger patients. Although partly due to higher burden of preexisting comorbidities, a higher DBT may also be responsible. (J Interven Cardiol 2011;24:357-365). ©2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21414028     DOI: 10.1111/j.1540-8183.2011.00634.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  7 in total

1.  Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI.

Authors:  Guo-Xiong Chen; Hong-Na Wang; Jin-Lin Zou; Xiao-Xu Yuan
Journal:  World J Emerg Med       Date:  2020

2.  Age-related treatment strategy and long-term outcome in acute myocardial infarction patients in the PCI era.

Authors:  Petr Kala; Jan Kanovsky; Richard Rokyta; Michal Smid; Jan Pospisil; Jiri Knot; Filip Rohac; Martin Poloczek; Tomas Ondrus; Maria Holicka; Jindrich Spinar; Jiri Jarkovsky; Ladislav Dusek
Journal:  BMC Cardiovasc Disord       Date:  2012-04-25       Impact factor: 2.298

3.  Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction.

Authors:  Peter Andreas Claussen; Michael Abdelnoor; Kristin M Kvakkestad; Jan Eritsland; Sigrun Halvorsen
Journal:  Vasc Health Risk Manag       Date:  2014-12-09

4.  Treatment choices in elderly patients with ST: elevation myocardial infarction-insights from the Vital Heart Response registry.

Authors:  Olga Toleva; Quazi Ibrahim; Neil Brass; Sunil Sookram; Robert Welsh
Journal:  Open Heart       Date:  2015-06-24

5.  Clinical outcomes of elderly South-East Asian patients in primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Authors:  Jieli Tong; Wen Wei Xiang; An Shing Ang; Wen Jun Sim; Kien Hong Quah; David Foo; Paul Jau Lueng Ong; Hee Hwa Ho
Journal:  J Geriatr Cardiol       Date:  2016-10       Impact factor: 3.327

6.  Development and validation of a clinical risk score to predict mortality after percutaneous coronary intervention.

Authors:  Joshua J S Wall; Javaid Iqbal; Michael Andrews; Dawn Teare; Mina Ghobrial; Thomas Hinton; Samuel Turton; Leila Quffa; Magdi El-Omar; Douglas G Fraser; Anjan Siotia; Julian Gunn
Journal:  Open Heart       Date:  2017-07-25

7.  Association of invasive treatment and lower mortality of patients ≥ 80 years with acute myocardial infarction: a propensity-matched analysis.

Authors:  Shuo-Lin Liu; Na-Qiong Wu; Meng Zhang; Jing-Lu Jin; Bing-Yang Zhou; Qian Dong; Jian-Jun Li
Journal:  J Geriatr Cardiol       Date:  2018-11       Impact factor: 3.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.